1 | INSM | Insmed Incorporated | 3.41% |
2 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.27% |
3 | NTRA | Natera, Inc. | 3.00% |
4 | BPMC | Blueprint Medicines Corporation | 2.99% |
5 | NBIX | Neurocrine Biosciences, Inc. | 2.96% |
6 | EXAS | Exact Sciences Corporation | 2.87% |
7 | INCY | Incyte Corporation | 2.56% |
8 | UTHR | United Therapeutics Corporation | 2.41% |
9 | GILD | Gilead Sciences, Inc. | 2.41% |
10 | AMGN | Amgen Inc. | 2.35% |
11 | VRTX | Vertex Pharmaceuticals Incorporated | 2.30% |
12 | BIIB | Biogen Inc. | 2.29% |
13 | ABBV | AbbVie Inc. | 2.22% |
14 | EXEL | Exelixis, Inc. | 2.20% |
15 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.99% |
16 | BBIO | BridgeBio Pharma, Inc. | 1.90% |
17 | REGN | Regeneron Pharmaceuticals, Inc. | 1.89% |
18 | MRNA | Moderna, Inc. | 1.84% |
19 | BMRN | BioMarin Pharmaceutical Inc. | 1.70% |
20 | RVMD | Revolution Medicines, Inc. | 1.53% |
21 | IONS | Ionis Pharmaceuticals, Inc. | 1.53% |
22 | CRSP | CRISPR Therapeutics AG | 1.52% |
23 | TGTX | TG Therapeutics, Inc. | 1.50% |
24 | HALO | Halozyme Therapeutics, Inc. | 1.39% |
25 | ROIV | Roivant Sciences Ltd. | 1.33% |
View XBI holdings |